FLASCO


 
 

Corporate Members

Diamond

Platinum

Gold

Silver

Latest News

Free PQRS Reporting Now Available Through QOPI®; No Additional Reporting Required 

Posted September 29, 2016

ASCO is pleased to announce that oncology practices can now complete all of their Physician Quality Reporting System (PQRS) requirements through the Quality Oncology Practice Initiative (QOPI®) platform. All users will be able to use the QOPI system to fulfill the Oncology Measures Group set of seven measures for PQRS reporting. QOPI is free to...

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Genetic/Familial High-Risk Assessment: Colorectal and Kidney Cancer

Posted September 29, 2016

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Genetic/Familial High-Risk Assessment: Colorectal. These NCCN Guidelines® are currently available as Version 2.2016.  The Discussion section has been updated to reflect the changes in the algorithm. (MS-1) *For your reference, the previous update (Version 1.2016) to the NCCN Guidelines for...

NCCN has published updates to the NCCN Guidelines® and NCCN Compendium® for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).

Posted September 29, 2016

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and NCCN Drugs & Biologics Compendium (NCCN Compendium®) for Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL). These NCCN Guidelines® are currently available as Version 1.2017.  ·         The NCCN Guidelines for CLL/SLL (previously included as part of NCCN Guidelines for Non-Hodgkin’s Lymphomas) have...

NCCN has published updates to the NCCN Guidelines® for Genetic/Familial High-Risk Assessment: Breast and Ovarian.

Posted September 22, 2016

NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Genetic/Familial High-Risk Assessment: Breast and Ovarian. These NCCN Guidelines® are currently available as Version 1.2017. Breast and Ovarian Cancer Risk Assessment (BR/OV-1) First column, 2nd bullet, “An individual with a breast cancer diagnosis meeting any of the following” For the 4th...

ASCO, ASTRO and SSO update guideline on postmastectomy radiotherapy

Posted September 22, 2016

Three leading national cancer organizations today issued a joint clinical practice guideline update for physicians treating women with breast cancer who have undergone a mastectomy. The update provides additional considerations for physicians to determine which patients might benefit from postmastectomy radiotherapy (PMRT). “We still don’t have a single, validated formula that can determine who needs...

Who’s Online

There are no users currently online